NCR1 and prostate carcinoma: However NK cells have been very scarcely studied in prostate cancer, excepted immunohistochemical (IHC) observations showing that the ligands for NKp30 and NKp46 are expressed on primary tumors and not on benign prostate hyperplasia [36].